#cetuximab

Early Diagnosis and Treatment of Cancer Series: Colorectal Cancer E-Book

Ebooks

Early Diagnosis and Treatment of Cancer Series: Colorectal Cancer E-Book

Susan Gearhart, Nita Ahuja

Ebooks

Medecine

Early Diagnosis and Treatment of Cancer Series: Colorectal Cancer E-Book

Susan Gearhart, Nita Ahuja

344 pages

English

Lire

Infos

Predictive role of multiple gene alterations in response to cetuximab in metastatic colorectal cancer: A single center study

Documents

Predictive role of multiple gene alterations in response to cetuximab in metastatic colorectal cancer: A single center study

Ulivi Paola, Capelli Laura, Valgiusti Martina, Zoli Wainer, Scarpi Emanuela, Chiadini Elisa, Rosetti Paola, Bravaccini Sara, Calistri Daniele, Saragoni Luca, Gardini Andrea, Ragazzini Angela, Frassineti Giovanni, Amadori Dino, Passardi Alessandro

Documents

Savoirs

Predictive role of multiple gene alterations in response to cetuximab in metastatic colorectal cancer: A single center study

8 pages

English

Lire

Infos

Management of EGFR-inhibitor associated rash: a retrospective study in 49 patients

Documents

Management of EGFR-inhibitor associated rash: a retrospective study in 49 patients

Gerber Peter, Meller Stephan, Eames Tatiana, Buhren Bettina, Schrumpf Holger, Hetzer Sonja, Ehmann Laura, Budach Wilfried, Bölke Edwin, Matuschek Christiane, Wollenberg Andreas, Homey Bernhard

Documents

Savoirs

Management of EGFR-inhibitor associated rash: a retrospective study in 49 patients

Gerber Peter, Meller Stephan, Eames Tatiana, Buhren Bettina, Schrumpf Holger, Hetzer Sonja, Ehmann Laura, Budach Wilfried, Bölke Edwin, Matuschek Christiane, Wollenberg Andreas, Homey Bernhard

7 pages

English

Lire

Infos

EGFR gene copy number as a predictive biomarker for the treatment of metastatic colorectal cancer with anti-EGFR monoclonal antibodies: a meta-analysis

Documents

EGFR gene copy number as a predictive biomarker for the treatment of metastatic colorectal cancer with anti-EGFR monoclonal antibodies: a meta-analysis

Yang Zu-Yao, Shen Wei-Xi, Hu Xue-Feng, Zheng Da-Yong, Wu Xin-Yin, Huang Ya-Fang, Chen Jin-Zhang, Mao Chen, Tang Jin-Ling, Tang

Documents

Savoirs

EGFR gene copy number as a predictive biomarker for the treatment of metastatic colorectal cancer with anti-EGFR monoclonal antibodies: a meta-analysis

Yang Zu-Yao, Shen Wei-Xi, Hu Xue-Feng, Zheng Da-Yong, Wu Xin-Yin, Huang Ya-Fang, Chen Jin-Zhang, Mao Chen, Tang Jin-Ling, Tang

9 pages

English

Lire

Infos

Efficient Blockade of Akt signaling is a determinant factor to overcome resistance to Matuzumab

Documents

Efficient Blockade of Akt signaling is a determinant factor to overcome resistance to Matuzumab

Meira, Mororó, Caetano, Batista Delano, Sternberg Cinthya, Ferreira, Almeida, Nóbrega

Documents

Savoirs

Efficient Blockade of Akt signaling is a determinant factor to overcome resistance to Matuzumab

Meira, Mororó, Caetano, Batista Delano, Sternberg Cinthya, Ferreira, Almeida, Nóbrega

13 pages

English

Lire

Infos

Phosphorylated AKT and MAPK expression in primary tumours and in corresponding metastases and clinical outcome in colorectal cancer patients receiving irinotecan-cetuximab

Documents

Phosphorylated AKT and MAPK expression in primary tumours and in corresponding metastases and clinical outcome in colorectal cancer patients receiving irinotecan-cetuximab

Scartozzi Mario, Giampieri Riccardo, Maccaroni Elena, Mandolesi Alessandra, Biagetti Simona, Alfonsi Simona, Giustini Lucio, Loretelli Cristian, Faloppi Luca, Bittoni Alessandro, Bianconi Maristella, Bearzi Italo, Cascinu Stefano, Del

Documents

Savoirs

Phosphorylated AKT and MAPK expression in primary tumours and in corresponding metastases and clinical outcome in colorectal cancer patients receiving irinotecan-cetuximab

10 pages

English

Lire

Infos

Radiochemoimmunotherapy with intensity-modulated concomitant boost: interim analysis of the REACH trial

Documents

Radiochemoimmunotherapy with intensity-modulated concomitant boost: interim analysis of the REACH trial

Jensen, Krauss Jürgen, Potthoff Karin, Simon Christian, Nikoghosyan, Lossner Karen, Debus Jürgen, Münter

Documents

Savoirs

Radiochemoimmunotherapy with intensity-modulated concomitant boost: interim analysis of the REACH trial

Jensen, Krauss Jürgen, Potthoff Karin, Simon Christian, Nikoghosyan, Lossner Karen, Debus Jürgen, Münter

9 pages

English

Lire

Infos

Combined use of anti-ErbB monoclonal antibodies and erlotinib enhances antibody-dependent cellular cytotoxicity of wild-type erlotinib-sensitive NSCLC cell lines

Documents

Combined use of anti-ErbB monoclonal antibodies and erlotinib enhances antibody-dependent cellular cytotoxicity of wild-type erlotinib-sensitive NSCLC cell lines

Cavazzoni Andrea, Alfieri, Cretella Daniele, Saccani Francesca, Ampollini Luca, Galetti Maricla, Quaini Federico, Graiani Gallia, Madeddu Denise, Mozzoni Paola, Galvani Elena, Bonelli Mara, Fumarola Claudia, Mutti Antonio, Carbognani Paolo, Tiseo Marcello, Barocelli Elisabetta, Petronini, Ardizzoni Andrea, La

Documents

Savoirs

Combined use of anti-ErbB monoclonal antibodies and erlotinib enhances antibody-dependent cellular cytotoxicity of wild-type erlotinib-sensitive NSCLC cell lines

14 pages

English

Lire

Infos